|
C3ORF23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.92169963170375E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.93900015435611E-10 |
| Normal-vs-Stage2 |
4.426200E-04 |
| Normal-vs-Stage3 |
7.27089999985608E-07 |
| Normal-vs-Stage4 |
1.034650E-01 |
| Stage1-vs-Stage2 |
8.044400E-01 |
| Stage1-vs-Stage3 |
3.549000E-01 |
| Stage1-vs-Stage4 |
1.711780E-01 |
| Stage2-vs-Stage3 |
4.208400E-01 |
| Stage2-vs-Stage4 |
3.702000E-01 |
| Stage3-vs-Stage4 |
1.167230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.19229992335113E-10 |
| Normal-vs-AfricanAmerican |
1.23450000000247E-07 |
| Normal-vs-Asian |
3.799800E-01 |
| Caucasian-vs-AfricanAmerican |
9.218000E-01 |
| Caucasian-vs-Asian |
3.319400E-01 |
| AfricanAmerican-vs-Asian |
3.127000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.02170502561216E-11 |
| Normal-vs-Female |
1.157180E-04 |
| Male-vs-Female |
2.299000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.65260000029433E-07 |
| Normal-vs-Extreme_Weight |
1.15309983783618E-11 |
| Normal-vs-Obese |
3.31570004785675E-09 |
| Normal-vs-Extreme_Obese |
6.791700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.783170E-01 |
| Normal_Weight-vs-Obese |
6.978400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.971600E-01 |
| Extreme_Weight-vs-Obese |
2.912600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.149400E-01 |
| Obese-vs-Extreme_Obese |
2.795400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.090400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.25199994815972E-09 |
| Normal-vs-Age(61-80Yrs) |
2.44629982937283E-10 |
| Normal-vs-Age(81-100Yrs) |
1.89459999999642E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.502830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.173630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.512420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.407600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.475000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.180600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.4665999504877E-09 |
| Normal-VS-Type2 PRCC |
1.28300037260942E-10 |
| Normal-VS-KIRP CIMP |
5.810400E-01 |
| Normal-VS-Unclassified PRCC |
2.32209999995181E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.784200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.047500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.842200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.424300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.950400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.175900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.29440039084739E-10 |
| Normal-vs-N1 |
1.369190E-04 |
| Normal-vs-N2 |
3.797100E-04 |
| N0-vs-N1 |
3.335600E-01 |
| N0-vs-N2 |
7.351600E-01 |
| N1-vs-N2 |
4.953600E-01 |
|
|
